|
Jun 25
|
Is Edwards Lifesciences Corporation's (NYSE:EW) Stock's Recent Performance A Reflection Of Its Financial Health?
|
|
Jun 24
|
Edwards Lifesciences Corporation (EW): A Bull Case Theory
|
|
Jun 24
|
NYSE Content Advisory: Pre-Market update + Wall Street watches the Middle East
|
|
Jun 24
|
BSX Raises 2025 Financial Outlook: What's Backing It?
|
|
Jun 17
|
3 Undervalued Asian Small Caps With Insider Buying
|
|
Jun 17
|
ISRG's Minimally Invasive Ecosystem Powers Surgical Precision
|
|
May 28
|
How Boston Scientific's Surprise Setback Bolstered Two Of Its Top Rivals
|
|
May 23
|
Edwards’ study demonstrates value in early aortic stenosis intervention
|
|
May 23
|
Edwards' New Late-Breaking Data on Severe AS Expected to Boost Stock
|
|
May 22
|
Citi shuffles MedTech stocks: BDX downgraded, ITGR raised; reiterates top pick
|
|
May 22
|
Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes
|
|
Apr 19
|
Edwards says eight-year data confirm long-term durability of Resilia tissue
|
|
Apr 18
|
Unlocking Q1 Potential of Edwards Lifesciences (EW): Exploring Wall Street Estimates for Key Metrics
|
|
Apr 18
|
Eight-Year Data Confirm Long-Term Durability of Edwards’ RESILIA Tissue
|
|
Apr 17
|
Solid TMTT Growth to Drive Edwards Lifesciences' Q1 Earnings
|
|
Apr 16
|
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025
|
|
Apr 15
|
Edwards receives CE mark for Sapien M3 mitral valve replacement device
|
|
Apr 14
|
Edwards secures CE mark for transfemoral mitral valve implant
|
|
Apr 14
|
Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System
|
|
Mar 10
|
Edwards Lifesciences Corporation (EW): Among the Top Stocks to Buy According to Citadel Investment Group
|